Center-Authored Papers

Filters: Author is Geyer Jr, Charles E  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Adult
Lyman GH, Green SJ, Ravdin PM, Geyer Jr CE, Russell CA, Balcerzak SP, Thomas Budd G, Martino S.  2004.  A Southwest Oncology Group Randomized Phase II Study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer.. Breast cancer research and treatment. 85(2):143-50. Abstract
Aged
Lyman GH, Green SJ, Ravdin PM, Geyer Jr CE, Russell CA, Balcerzak SP, Thomas Budd G, Martino S.  2004.  A Southwest Oncology Group Randomized Phase II Study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer.. Breast cancer research and treatment. 85(2):143-50. Abstract
Antineoplastic Combined Chemotherapy Protocols
Lyman GH, Green SJ, Ravdin PM, Geyer Jr CE, Russell CA, Balcerzak SP, Thomas Budd G, Martino S.  2004.  A Southwest Oncology Group Randomized Phase II Study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer.. Breast cancer research and treatment. 85(2):143-50. Abstract
Breast Neoplasms
Lyman GH, Green SJ, Ravdin PM, Geyer Jr CE, Russell CA, Balcerzak SP, Thomas Budd G, Martino S.  2004.  A Southwest Oncology Group Randomized Phase II Study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer.. Breast cancer research and treatment. 85(2):143-50. Abstract
Cyclophosphamide
Lyman GH, Green SJ, Ravdin PM, Geyer Jr CE, Russell CA, Balcerzak SP, Thomas Budd G, Martino S.  2004.  A Southwest Oncology Group Randomized Phase II Study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer.. Breast cancer research and treatment. 85(2):143-50. Abstract
Doxorubicin
Lyman GH, Green SJ, Ravdin PM, Geyer Jr CE, Russell CA, Balcerzak SP, Thomas Budd G, Martino S.  2004.  A Southwest Oncology Group Randomized Phase II Study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer.. Breast cancer research and treatment. 85(2):143-50. Abstract
Female
Lyman GH, Green SJ, Ravdin PM, Geyer Jr CE, Russell CA, Balcerzak SP, Thomas Budd G, Martino S.  2004.  A Southwest Oncology Group Randomized Phase II Study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer.. Breast cancer research and treatment. 85(2):143-50. Abstract
Humans
Lyman GH, Green SJ, Ravdin PM, Geyer Jr CE, Russell CA, Balcerzak SP, Thomas Budd G, Martino S.  2004.  A Southwest Oncology Group Randomized Phase II Study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer.. Breast cancer research and treatment. 85(2):143-50. Abstract
Infusions, Intravenous
Lyman GH, Green SJ, Ravdin PM, Geyer Jr CE, Russell CA, Balcerzak SP, Thomas Budd G, Martino S.  2004.  A Southwest Oncology Group Randomized Phase II Study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer.. Breast cancer research and treatment. 85(2):143-50. Abstract
Middle Aged
Lyman GH, Green SJ, Ravdin PM, Geyer Jr CE, Russell CA, Balcerzak SP, Thomas Budd G, Martino S.  2004.  A Southwest Oncology Group Randomized Phase II Study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer.. Breast cancer research and treatment. 85(2):143-50. Abstract
Neoplasm Metastasis
Lyman GH, Green SJ, Ravdin PM, Geyer Jr CE, Russell CA, Balcerzak SP, Thomas Budd G, Martino S.  2004.  A Southwest Oncology Group Randomized Phase II Study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer.. Breast cancer research and treatment. 85(2):143-50. Abstract
Treatment Outcome
Lyman GH, Green SJ, Ravdin PM, Geyer Jr CE, Russell CA, Balcerzak SP, Thomas Budd G, Martino S.  2004.  A Southwest Oncology Group Randomized Phase II Study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer.. Breast cancer research and treatment. 85(2):143-50. Abstract